Home/Filings/4/0000905148-24-000966
4//SEC Filing

Ahmad Qasim Iftikhar 4

Accession 0000905148-24-000966

CIK 0001865494other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:18 PM ET

Size

5.3 KB

Accession

0000905148-24-000966

Insider Transaction Report

Form 4
Period: 2024-03-15
Ahmad Qasim Iftikhar
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-15+280,000280,000 total
    Exercise: $1.65Exp: 2034-03-15Common Stock (280,000 underlying)
Footnotes (1)
  • [F1]One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.

Documents

1 file

Issuer

IO Biotech, Inc.

CIK 0001865494

Entity typeother

Related Parties

1
  • filerCIK 0001985801

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:18 PM ET
Size
5.3 KB